Are there other Purple Beam Teams representing Rad Onc? We have one and are sitting 3rd place in DFW! I’ll dye my hair purple if top 3. Feel free to suggest what I should do if we can overtake ‘Watch Me Whipple’ Patricio Polanco Lan Vu currently sitting #2. Great cause!

If radiation had an accelerated approval pathway - also based on surrogate endpoints like response rate - it would probably be approved in most settings.

Which doesn’t make sense. Just FYI.

Getting excited for #ASCO24
Abstract titles are officially out 👀
conferences.asco.org/am/abstracts

And no surprise, for #bcsm the reign of ADCs continues. At first glance, some anticipated results for Dato-DXd and T-DXd from Rebecca Shatsky, MD FabriceAndre and Sonia Pernas. 👏🏻

TODAY'S THE DAY WE'VE ALL BEEN WAITING FOR! 💜👟

Share your photos and videos on social media using #PanCANPurpleStride and PanCAN to join the thousands raising awareness and funds today! 📲

Thank you for all that you do for #pancreaticcancer patients. 💜

ESOPEC IN THE PLENARY:
Well this is quite suggestive.
Has this study finally ended the decades long debate of the utility of RT, and the more recent FLOT vs CROSS debate, in the locally advanced setting of esophageal/GEJ adenocarcinoma? Let’s hope.

Shaalan Beg MD MBA FASCO Dr. Nina Niu Sanford Arjun Gupta DrTylerStewart Efrat Dotan MD Dr Beg… please don’t bring back sore memories… lol
This was our humble attempt to use wearable device to define performance status

ascopubs.org/doi/pdfdirect/…

Pleased to share the official X account of ASCO #pallonc Community of Practice #PallOncCoP . Please give a follow for updates on upcoming events/connections. Thanks for inspiration Fernando Diaz, MD and rest of the amazing CoP. #supponc Looking forward to #ASCO24

U.S. FDA approved Anktiva (nogapendekin alfa inbakicept-pmln) for BCG-unresponsive non-muscle invasive bladder cancer with impressive results. In a clinical trial, 62% of patients achieved a complete response, with 58% maintaining this response for at least 12 months and 40% for…

1/ The long-awaited OS results from #KEYNOTE -564 are out NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC .

nejm.org/doi/full/10.10…

GI Series: #UpperGi algorithm, w/ Sam Klempner to reiterate the current landscape:

Full Discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/upperGIalgo-20…
- Also on the “Oncology Brothers” podcast

#OncTwitter CancerNetwork® #MedTwitter #GISM

TL:DR- AI didn't make physicians inbox work more efficient. Interesting study.

AI-Generated Draft Replies Integrated Into Health Records and Physicians’ Electronic Communication jamanetwork.com/journals/jaman…

How many days until #PanCANPurpleStride ? 👟💜

🖐️ FIVE! 🖐️ There's still time to join us at the ultimate walk to end #pancreaticcancer , this Saturday, April 27 in a community near you! Register for free today at ➡️ purplestride.org

Owing to concerns for aspiration and delayed gastric emptying, GLP-1 drugs are recommended to be withheld before surgery. New data suggest this may not be necessary
jamanetwork.com/journals/jama/… JAMA Anjali Dixit, MD, MPH Stanford Anesthesiology

“When Cancer Hits the Oncologist’s Home”. On the anniversary of his passing, I share a piece I published The Oncologist on my experience as a cancer doctor, during my father-in-law’s cancer journey. He’s a great man who beat cancer by fighting the cancer. RIP
theoncologist.onlinelibrary.wiley.com/doi/full/10.16…

The #BCSM community is crushed by the news of swaggsheila's passing. God Speed, Sheila.

I'm a #doctor — here's what to know about rising #cancer rates in young people nypost.com/2024/04/18/lif… via New York Post NewYork-Presbyterian Weill Cornell Medicine ASCO WCM GI Cancer WCM Englander Institute for Precision Medicine

💜 Pyjamas for PanCan time! 💜

We've got our PJ's on, have you?

Join us in saying ‘goodnight’ to pancreatic cancer! 💤

If you haven't signed up, there is still time - join us anytime this month! 👉 pancreaticcanceraction.org/take-action/fu…

This was a special year at the #ASCOAdvocacySummit
1) Telemedicine bill CONNECT for Health #HR4189
2) Support ⬆️ cancer research funding
3) Ending drug shortages
These issues are more relevant to clinical care than ever.
Thank you:
Beth Van Duyne
Congresswoman Jasmine Crockett
Lloyd Doggett

The struggle is real for impact of cancer on our communities. It requires the effort of many. #ASCOAdvocacySummit We need to address #DrugShortages , #telehealth , increases in #CancerResearchFunding . Changes can occur thru #Advocacy and #collaboration The ASCO Post AdvocateCollaborative (ACE)

“I recommend we have a robust social media presence to educate...You don’t need thousands of followers...It’s not just 1 person making change, it’s all of us…You’ve already taken 1 step towards making change by being here.”
Thx Dr. Glaucomflecken for coming to #ASCOAdvocacySummit !